The Exondys 51 market is witnessing steady growth over the forecast period, supported by advancements in molecular genetics, expansion of personalized neuromuscular care.
Read More
The Evkeeza market is witnessing steady growth over the forecast period, supported by increasing genetic screening for lipid disorders, rising adoption of biologics.
Read More
The Evithrom market is witnessing steady growth over the forecast period, supported by growth in surgical interventions, rising accident and trauma rates.
Read More
The Evicel market is witnessing steady growth over the forecast period, supported by growth in minimally invasive surgeries, rising surgical volumes.
Read More
The Evenity market is witnessing steady growth over the forecast period, supported by growing awareness of bone health, increasing osteoporosis screening.
Read More
The Evarrest market is witnessing steady growth over the forecast period, supported by growth in complex surgical procedures, rising trauma incidence.
Read More
The Euvichol Or Euvichol-Plus market is witnessing steady growth over the forecast period, supported by rising incidence of nafld, expanding liver disease screening programs.
Read More
The Esperoct market is witnessing steady growth over the forecast period, supported by increasing adoption of extended half-life therapies, expansion of homecare treatment models.
Read More
The Erwinaze/Spectrila market is witnessing steady growth over the forecast period, supported by continued demand for allergy-safe therapies, advancements in enzyme drug stability.
Read More
The Ervebo market is witnessing steady growth over the forecast period, supported by strengthening of global pandemic preparedness, expansion of government vaccine stockpiles.
Read More